Agency / Source: Werbeagentur & PR-Agentur co-operate

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Diapharm Obtains Europe’s First Traditional Herbal Registration with Minerals - Pharmaceutical services provider Diapharm has registered a new product to support cardiovascular function and protect against climatic stress which will be marketed by its pooling partners
Diapharm Obtains Europe’s First Traditional Herbal Registration with Minerals

 

PRZOOM - /newswire/ - Muenster, North Rhine-Westfalia, Germany, 2010/10/04 - Pharmaceutical services provider Diapharm has registered a new product to support cardiovascular function and protect against climatic stress which will be marketed by its pooling partners.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The product contains 40mg hawthorn extract and 150mg of both potassium and magnesium salts, making it Europe’s first traditional herbal medicinal product to be combined with minerals. Following successful registration by the German Federal Institute for Drugs and Medical Devices (BfArM) by the end of September 2010, Diapharm is also seeking to register the product in more EU countries, including Austria and the United Kingdom.

"We are particularly proud to have obtained the first registration for our hawthorn combination product in Germany,” says Dr. Rainer Kolkmann at Diapharm. "The German Drug Authorities are very strict in their regulation of traditional herbal medicinal products in line with EU directive 2004/24/EC. But in this case, BfArM is leading the way."

However, it is not Diapharm who will be marketing the new hawthorn product in Germany. This task will instead be performed by pooling partners. The same is true in other countries where registration applications are submitted: Diapharm will perform the regulatory duties and then transfer the dossiers and registrations to other pharmaceutical companies for sales and marketing. Approximately one quarter of all traditional herbal medicinal products in the European Union originate from Diapharm in this way.

Diapharm (diapharm.de) is a full-service provider to the healthcare industry. Founded in 1988, Diapharm supports pharmaceutical companies in all questions concerning regulatory affairs, medical & clinical development, quality management and business development. Its activities focus on the sectors of medicinal products, food supplements and dietetic food, medical devices and cosmetics. With about 100 employees, Diapharm is at the service of multinational companies as well as of recent start-ups and small to mid-sized businesses.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Werbeagentur & PR-Agentur co-operate

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Diapharm Obtains Europe’s First Traditional Herbal Registration with Minerals

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Christian Rieke - Co-Operate.net 
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Werbeagentur & PR-Agentur co-operate securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Werbeagentur & PR-Agentur co-operate / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

SCHOTT Pharma Expands Portfolio for Sensitive Biologics with CartriQ® BioPure
Ojemda® Approved in The European Union as the First Targeted Therapy in Relapsed or Refractory Pediatric Low-grade Glioma
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition
Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
Ono Pharma Announces Transfer of the Manufacturing and Marketing Approval Authorization for Opalmon® Tablets and Prostandin® Ointment
Ono Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory
SCHOTT Pharma Launches EVERIC® Lyo & Amber Vials for Light-sensitive ADCs
Arbitration Tribunal Upholds Ipsen’s Termination of R&D Agreement with Galderma

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Limelon Advertising, Co.

Visit  RightITnow, Inc.







 
  ©2005-2026 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today